BCX
BIOCELTIX GPW LISTED

Shareholders

as of September 23, 2026 · source: notifications under Art. 69 of the Offering Act · 4 entities above 5% of votes

FREE FLOAT
62.19%
3,440,600 shares
LARGEST STAKE
14.02%
Fundusze zarządzane przez PZU TFI S.A.
TOP 3 CONCENTRATION
31.2%
3 entities above 5% of votes
LATEST CHANGE
July 16, 2026
ESPI (wykaz z WZ)

Ownership structure

stakes per latest notifications · shares outstanding: 5,532,253 (report, Sep 23, 2026)
SHAREHOLDERS ≥5% OF VOTES 37.81% FREE FLOAT 62.19%
Fundusze zarządzane przez PZU TFI S.A. 14.02%
775,437 shares NOTIFICATION: Sep 23, 2026
TOTAL Fundusz Inwestycyjny Zamknięty 8.67%
479,500 shares NOTIFICATION: Sep 23, 2026
Kvarko Group ASI sp. z o.o. 8.51%
470,953 shares NOTIFICATION: Sep 23, 2026
Łukasz Bzdzion 6.61%
365,763 shares NOTIFICATION: Sep 23, 2026
FREE FLOAT — BELOW 5% OF VOTES
Alternative Solution ASI S.A. 2.47%
— NOTIFICATION: Jul 16, 2026
Government of Norway 2.44%
— NOTIFICATION: Jul 16, 2026
Other 57.28%
3,168,600 shares composition undisclosed

Capital and votes

Number of shares
5,532,253
ISIN
PLBCLTX00019
Sector
Biotechnologia
Market
GPW
Country
PL
Listing date
November 01, 2021

Where this data comes from

The structure is built from notifications shareholders file after crossing 5%, 10%, 15%, 20%, 25%, 33%, 50%, 75% and 90% of votes.

Below 5% there is no disclosure obligation, so the remaining capital is shown collectively as free float — its composition is not publicly known.

Stakes are not updated in real time. The date next to each entity is its last notification date, not today's date.

The share count behind every percentage comes from the newest (by as-of date) periodic report or art. 69 notification — not from the company's GPW/NewConnect profile.